The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Eiger BioPharmaceuticals, Inc(NASDAQ:EIGR) 
Eiger BioPharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of targeted therapies for rare and ultra-rare diseases in the United States and internationally. Its lead product candidate is Lonafarnib, an orally bioavailable, small mole...
Website: http://www.eigerbio.com
Founded: 2000
Full Time Employees: 29
Sector: Healthcare
Industry: Biotechnology
Eiger BioPharmaceuticals Days Payable Outstanding ttm (DPO)
Eiger BioPharmaceuticals Days Receivable Outstanding ttm (DSO)
Eiger BioPharmaceuticals Days Inventory Outstanding ttm (DIO)
Eiger BioPharmaceuticals Op Cashflow Per Share ttm
Eiger BioPharmaceuticals Free Cashflow Per Share ttm
Eiger BioPharmaceuticals Cash Per Share ttm
Eiger BioPharmaceuticals P/S ratio ttm
Eiger BioPharmaceuticals (GAAP) P/E ratio ttm
Eiger BioPharmaceuticals P/B ratio ttm
No extra charts and metrics for this ticker.